David Waugh

Professor David Waugh is the Head of School of Biomedical Sciences at Queensland University of Technology (QUT) and holds the title of Adjunct Professor of Molecular Oncology and Therapeutics. His research focuses on understanding inflammatory signals contributing to prostate cancer progression, particularly the role of chemokines in aggressive prostate tumor behavior. His work aims to identify therapeutic targets to improve outcomes for advanced prostate cancer patients.

• Research Interests: Molecular oncology, prostate cancer biology, tumor microenvironment, inflammatory signaling pathways.
• Professional Memberships: AACR, ASBMB, ASPET.

Key research themes include developing bioengineered microenvironments for prostate cancer studies and exploring cytokine/chemokine inhibition strategies. His articles (2018–2025) span topics like tumor-associated macrophage re-education, lipid metabolism in antiandrogen therapy, and biomarker-driven precision oncology. Current projects involve engineering bone and adipose tissue models to study metastatic mechanisms.

Supervision focuses on precision oncology workflows, tumor microenvironment engineering, and novel therapeutic approaches targeting neovascular responses. His research integrates experimental models with computational methods to address clinical challenges in prostate cancer management.